Why the study?
Myocardial inflammation is a major cause of cardiovascular morbidity and sudden cardiac death in athletes, and emerging imaging and biopsy data have highlighted challenges in managing myocarditis and inflammatory cardiomyopathy.
This review provides an updated overview of the epidemiology, pathophysiology, diagnosis, and treatment of myocardial inflammation in athletes, focusing on sports eligibility and sudden cardiac death prevention.
Myocardial inflammation is an important cause of cardiovascular morbidity and sudden cardiac death in athletes. The relationship between sports practice and myocardial inflammation is complex, and recent data from studies concerning cardiac magnetic resonance imaging and endomyocardial biopsy have substantially added to our understanding of the challenges encountered in the comprehensive care of athletes with myocarditis or inflammatory cardiomyopathy (ICM). In this review, we provide an overview of the current knowledge on the epidemiology, pathophysiology, diagnosis, and treatment of myocarditis, ICM, and myopericarditis/perimyocarditis in athletes, with a special emphasis on arrhythmias, patient-tailored therapies, and sports eligibility issues.
No takes yet. Share an insight, caveat, or question.
Compagnucci et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: